HKPD

Cellyan Biotechnology Co., Ltd

$1.57

3.28%
SectorHealthcareIndustryMedical DistributionCountryHong Kong

Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services. In addition, it provides value-added services such as labeling, extended storage, product inspection, batch processing, and logistics support, as well as sales of health supplements and non-pharmaceutical products. The company serves e-commerce platform logistics partners, merchants, and Chinese e-commerce platforms as well as pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.

Source: Yahoo Finance
Q-Score35/ 100
Market Cap$3.9M
P/E—
Dividend Yield0.00%
52-Week Range—
Next Earnings—
Analysts—
Beta1.26
AI summary

Price & performance

1M-21.3%
3M-72.8%
YTD-88.1%
1Y-91.7%
52-week range—
Beta1.26
Full chart and returns against a benchmark

Q-Score

35/ 100

Quality against peers; 50 is the peer median.

Growth—
Risk32
Performance16
Valuation64
Profitability49
Leverage43
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$20.3M+21.7%
Net income-$27.1K-102.0%
Net margin-0.1%-8.1 pts
Historical fundamentals

Red flags in filings

2active red flags
Going-concern doubtAug 7, 2026
Late filing noticeJul 31, 2026
Filings, findings and the timeline

Revenue exposure

Regions, segments, customers and suppliers

Valuation

HKPDIndustryP/E—28.60P/S0.240.25EV/EBITDA—17.46P/B0.760.76PEG—0.72
Dividend yield0.00%
Every valuation metric